Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of DAG1 mRNA | affects expression | 16483693
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride affects the expression of DAG1 mRNA | affects expression | 17484886
|
D003513 |
Cycloheximide |
Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of DAG1 mRNA] | decreases expression|decreases reaction | 11007951
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of DAG1 mRNA | decreases expression | 20106945
|
D004317 |
Doxorubicin |
DAG1 protein affects the susceptibility to Doxorubicin | affects response to substance | 16217747
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of DAG1 mRNA | decreases expression | 17475347
|
C030110 |
oxaliplatin |
oxaliplatin results in increased expression of DAG1 mRNA | increases expression | 17762391
|
D010126 |
Ozone |
Ozone results in decreased expression of DAG1 mRNA | decreases expression | 16716893
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of DAG1 mRNA | increases expression | 18301758
|
D020849 |
Raloxifene |
Raloxifene results in increased expression of DAG1 mRNA | increases expression | 16497877
|
D013749 |
Tetrachlorodibenzodioxin |
Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of DAG1 mRNA] | decreases expression|decreases reaction | 11007951
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of DAG1 mRNA | decreases expression | 11007951
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with AHR gene mutant form] results in decreased expression of DAG1 mRNA | affects cotreatment|decreases expression | 19465110
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of DAG1 mRNA | increases expression | 16267337
|
D014212 |
Tretinoin |
Tretinoin results in decreased expression of DAG1 mRNA | decreases expression | 17045167
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of DAG1 mRNA | increases expression | 16236135
|
C025643 |
vinclozolin |
vinclozolin affects the expression of DAG1 mRNA | affects expression | 19015723
|
C025643 |
vinclozolin |
vinclozolin results in decreased expression of DAG1 mRNA | decreases expression | 18042343
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.96 | 11752688 15322242 14514962 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.68 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.08 | 17505938 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.20 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
4.45 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
4.45 | 14692618 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
10.30 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
10.30 | 16835633 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
11.78 | 21441931 |
MESH:D000419 |
Albuminuria |
|
Raloxifene |
11.78 | 17451421 17308373 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.68 | 15955085 |
MESH:D000544 |
Alzheimer Disease |
|
Ozone |
4.43 | 15513908 |
MESH:D000544 |
Alzheimer Disease |
|
Raloxifene |
4.43 | 15800139 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.02 | 11748828 |
MESH:D001008 |
Anxiety Disorders |
|
vinclozolin |
3.70 | 19015723 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.57 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
7.37 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
7.37 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
4.73 | 15570426 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
4.73 | 16292516 |
MESH:D001249 |
Asthma |
|
Ozone |
5.03 | 17854713 16373670 |
MESH:D001249 |
Asthma |
|
Tretinoin |
5.03 | 16456186 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.50 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
15.76 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
15.76 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
15.76 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.92 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.81 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.83 | 14601052 |
MESH:D001930 |
Brain Injuries |
|
Raloxifene |
4.58 | 16580743 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.88 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
1.98 | 18234424 16115903 18382427 16322301 15136595 15994142 15692762 17426702 16264153 11325840 18628466 15567936 16826403 15668708 16096432 15634643 18695136 17983394 15993339 16935488 15939500 17369602 19526202 16595493 |
MESH:D001943 |
Breast Neoplasms |
|
Raloxifene |
1.98 | 15572757 17440819 15758505 15775269 16912660 17242785 17893378 16837676 17952589 17595753 17049068 17261762 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.98 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
1.98 | 16166294 16873071 16443354 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
3.74 | 16777450 17626835 18417511 18315731 15516495 19059883 14754758 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.71 | 16813970 |
MESH:D002100 |
Cachexia |
|
Ozone |
4.86 | 16183385 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.88 | 16192424 3786805 16050911 18705752 15673190 16011737 15700767 10355542 16227642 16124888 15721981 16097048 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
4.94 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.86 | 16835633 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.29 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
4.72 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
4.72 | 17876044 16234567 16023760 18059187 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
4.72 | 1917145 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
3.19 | 16201981 1485588 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
4.85 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
4.85 | 16096774 16051514 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Raloxifene |
4.15 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.41 | 16120746 18670907 18850075 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.58 | 16952015 15476868 16364871 17519947 17329180 16731534 17131338 16109756 16612575 15505089 17928571 16269455 17007740 17308081 15792986 17382496 15811867 17351982 16455267 17924179 16242529 16651473 16278810 17974986 18627295 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.97 | 17334414 16243910 |
MESH:D002318 |
Cardiovascular Diseases |
|
Raloxifene |
3.50 | 15775269 |
MESH:D002386 |
Cataract |
|
Tretinoin |
3.14 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
2.58 | 12371664 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.71 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.23 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
13.70 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
13.70 | 16105132 15861022 17681005 17333356 16919318 17110522 11677210 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
13.70 | 19176532 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.29 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.87 | 15668235 16354765 12621046 15340226 8697196 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.87 | 9407595 |
MESH:D003072 |
Cognition Disorders |
|
Raloxifene |
4.72 | 15800139 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.81 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
oxaliplatin |
3.18 | 16024531 16510598 16004971 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
3.01 | 18259882 18802399 |
MESH:D015179 |
Colorectal Neoplasms |
|
oxaliplatin |
3.01 | 18509181 17255274 17401013 17695437 17594712 18448328 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.13 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.47 | 10048152 15322242 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
2.47 | 14991402 16925845 9664655 10589399 9224671 17551590 9211117 9142499 9125849 8800419 |
MESH:D003456 |
Cryptorchidism |
|
vinclozolin |
4.44 | 14966744 |
MESH:D003865 |
Depressive Disorder, Major |
|
Raloxifene |
4.23 | 17474826 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.46 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.68 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Raloxifene |
4.01 | 17308373 15920148 17451421 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
6.37 | 15998439 16227642 7120509 16177239 6623471 19085960 10915739 7440962 6884620 17522070 21278145 9327722 11566570 15968718 15027814 4309450 7179309 2869522 10092053 19336974 3786805 3732212 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
6.37 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.37 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
8.31 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
8.31 | 11462148 |
MESH:D004487 |
Edema |
|
pirinixic acid |
11.91 | 12083418 |
MESH:D004487 |
Edema |
|
Raloxifene |
11.91 | 15860553 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
11.91 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
12.40 | 18230668 15322242 16714409 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
12.40 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
9.43 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Raloxifene |
9.43 | 15845917 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
7.76 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
7.76 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.10 | 9294722 10568697 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.29 | 18037988 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
9.04 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
9.04 | 16938888 9664655 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
25.57 | 16045604 12631006 12795759 15959796 17595544 16239168 61145 19224547 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
25.57 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
25.57 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
25.57 | 20131406 19236843 |
MESH:D005234 |
Fatty Liver |
|
Raloxifene |
25.57 | 17473493 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.56 | 11858732 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.70 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
22.06 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
22.06 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
22.06 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
22.06 | 17994277 |
MESH:D030342 |
Genetic Diseases, Inborn |
|
vinclozolin |
5.05 | 16973722 |
MESH:D005832 |
Genital Diseases, Male |
|
vinclozolin |
5.43 | 16417039 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.34 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
7.41 | 17150277 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
7.41 | 17312396 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.73 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
8.02 | 15692506 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
8.02 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.29 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.67 | 10048152 11294989 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
6.67 | 9664655 14991402 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
8.03 | 16495754 16879835 16244372 12587719 18006777 18674790 17875725 14766674 16330681 16244371 17888722 16144979 16707910 |
MESH:D006331 |
Heart Diseases |
|
Raloxifene |
8.03 | 11110106 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
7.21 | 17481944 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
7.21 | 20558911 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.98 | 15692506 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.54 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.42 | 11000095 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
3.69 | 19110552 19900420 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
8.61 | 16221962 19176532 18467677 19772884 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
8.61 | 15340226 16120746 12621046 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
3.48 | 17606976 15147373 18501091 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.18 | 16959395 8697196 16354765 15340226 18606429 |
MESH:D006930 |
Hyperalgesia |
|
oxaliplatin |
8.45 | 17418472 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
8.45 | 16870215 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.65 | 16899240 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.67 | 16778211 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.26 | 20558911 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
8.75 | 10903974 |
MESH:D006973 |
Hypertension |
|
Raloxifene |
8.75 | 15787275 17577099 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
8.75 | 18670907 18850075 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
4.19 | 15338365 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.91 | 16569931 16945680 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.55 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
6.84 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
vinclozolin |
6.84 | 16467254 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.89 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.68 | 16306350 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.87 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
10.21 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
10.21 | 15992940 17551590 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.58 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
6.26 | 18776723 10903974 8314463 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
6.26 | 16775033 15699352 15369732 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
4.23 | 16707910 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
2.80 | 12371664 |
MESH:D007835 |
Lassa Fever |
marker/mechanism |
|
| 17287727 |
MESH:D007889 |
Leiomyoma |
|
Raloxifene |
4.58 | 16973256 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.81 | 17143497 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.29 | 16085563 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.78 | 19285840 16482212 16932348 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.09 | 19850784 17596541 16294345 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.20 | 19029980 16140955 16935935 19225113 16788101 16331271 16823087 9834237 17649720 17506722 17301526 17368321 17294898 16766008 17712046 15748426 19642359 12679006 19035177 17217047 16891316 17107899 17361223 19075265 17339181 |
MESH:D007984 |
Leydig Cell Tumor |
|
vinclozolin |
4.85 | 16417039 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.36 | 9224671 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
2.85 | 17334410 21278145 11408273 16221502 17174718 16239168 16943688 11903743 17157831 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
6.83 | 16027843 16015684 18412020 18472094 18429990 14512876 12546737 14748882 15362042 17557913 18339082 14716833 18205269 18376398 18210741 18472332 15123356 17714472 18395914 12898905 15730626 17761835 16248980 16136751 15338365 17976157 10355542 16638106 17721639 18054572 18279442 15959796 15673190 14620537 17805973 17698563 18705752 17869086 15057751 16011737 16116963 15370692 18317297 16097048 17944888 17900296 13678700 12649538 14724832 12445418 15893842 15818738 15650968 12666154 15996030 14716496 12958196 15925388 20821823 12632514 16033810 17823541 12741479 17922224 11481614 18251166 12445421 17481882 17640975 18006644 17766677 17708605 12586293 18277467 18187930 18395095 15052691 12609069 15876570 18263696 18418968 15931870 17631135 12389079 12632512 18420326 16192424 18166357 18481824 12667390 17565644 17525996 18156304 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
6.83 | 16439617 16595196 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
6.83 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
6.83 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
6.83 | 18397230 16248980 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
2.10 | 16246199 15720792 15830285 17285989 16964402 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
4.27 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
3.77 | 14706259 16899240 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
7.50 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
7.50 | 16377806 20007298 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
7.50 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
10.14 | 15583823 12014681 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
10.14 | 17085340 16842330 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
10.14 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
Ozone |
3.43 | 19066396 8266340 |
MESH:D055370 |
Lung Injury |
|
Ozone |
3.95 | 20417186 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
3.51 | 17418594 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
Ozone |
3.51 | 7614698 8597069 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.51 | 19555203 11884234 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
3.52 | 16098063 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
3.86 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.67 | 15621674 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
3.08 | 15458769 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.81 | 17453147 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
3.47 | 16827129 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
3.47 | 16752155 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.53 | 16940565 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
3.09 | 17638057 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.92 | 16801185 |
MESH:D008679 |
Metaplasia |
|
Ozone |
5.24 | 10496685 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.58 | 15792986 |
MESH:D018200 |
Mixed Tumor, Mullerian |
|
Raloxifene |
5.69 | 15863610 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.91 | 17415656 |
MESH:D009101 |
Multiple Myeloma |
|
Raloxifene |
3.49 | 16497877 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.61 | 16239165 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
3.12 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
5.81 | 15857846 19429709 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
5.81 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.08 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.01 | 16411023 |
MESH:D009232 |
Myxoma |
|
Raloxifene |
5.69 | 16343187 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
2.98 | 18259882 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
5.03 | 17405874 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
5.03 | 16946489 16594593 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.87 | 16899518 16636307 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.58 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
9.54 | 18481113 19348381 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
9.54 | 15640375 16889571 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
9.83 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
9.83 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
3.10 | 9142499 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.30 | 15555623 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.83 | 20558911 |
MESH:D010024 |
Osteoporosis |
|
Raloxifene |
3.44 | 17882678 15775268 19059307 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Raloxifene |
4.31 | 17823083 15579764 17893378 15758505 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.18 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
2.37 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
2.97 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
2.49 | 15976015 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.77 | 11578682 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.38 | 12520081 |
MESH:D010538 |
Peritonitis |
|
Ozone |
4.23 | 16369182 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.29 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.29 | 17638057 |
MESH:D011014 |
Pneumonia |
|
Ozone |
4.51 | 18381685 18929643 18007984 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.65 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.29 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
9.88 | 11222880 11896295 11399792 11118676 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
vinclozolin |
9.88 | 18042343 18220299 19015723 |
MESH:D011469 |
Prostatic Diseases |
|
vinclozolin |
5.05 | 18220299 |
MESH:D011471 |
Prostatic Neoplasms |
marker/mechanism |
|
| 17013881 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
3.50 | 15749863 16729912 16888761 15897917 16868541 18437689 |
MESH:D011471 |
Prostatic Neoplasms |
|
Raloxifene |
3.50 | 16220300 16536755 15731164 |
MESH:D011472 |
Prostatitis |
|
vinclozolin |
5.05 | 18629315 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.69 | 16636307 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.43 | 15861022 16919318 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.25 | 16882103 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.91 | 16723453 |
MESH:D011693 |
Purpura |
|
Raloxifene |
5.69 | 15770314 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.33 | 17922066 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.42 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.93 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
4.19 | 16283617 16116481 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
4.06 | 17203757 16767912 15675481 18313854 17710206 15625365 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
4.34 | 14601052 16326096 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.91 | 17846226 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
9.68 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
9.68 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
9.68 | 16467112 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.67 | 17203757 16767912 15625365 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
4.08 | 16709447 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
1.80 | 17261132 |
MESH:D020521 |
Stroke |
|
Raloxifene |
3.89 | 16837676 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.71 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.22 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.04 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
7.52 | 17909728 16010429 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
7.52 | 16026305 17045167 |
MESH:D013978 |
Tibial Fractures |
|
Raloxifene |
5.34 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.86 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.27 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
5.48 | 17653716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Raloxifene |
5.48 | 17572228 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
3.75 | 16129372 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.39 | 14692618 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.74 | 16752155 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.12 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.73 | 12125929 |
MESH:D054556 |
Venous Thromboembolism |
|
Raloxifene |
5.34 | 16837676 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.62 | 14671159 15869587 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.33 | 17678736 16364871 17334414 17638931 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.15 | 16761959 |
MESH:D014846 |
Vulvar Neoplasms |
|
Raloxifene |
5.69 | 16343187 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.38 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
4.04 | 16287080 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.58 | 17120751 |